RB
Radhika Beri
About Radhika Beri
Data last updated:
Radhika Beri is a Director at Recombigen Laboratories Private Limited (since 2022). The companies operate in Healthcare. Recombigen Laboratories Private Limited reported revenue of ₹17.85 Cr (FY 2025). Earlier, Radhika Beri was a Director at Clonazyme Healthcare Private Limited (from 1995).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Apr 2022 | 1999 | ₹17.85 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 03 Apr 1995 | 1995 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Radhika Beri
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rajesh Beri | 01188317 | Recombigen Laboratories Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Radhika Beri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Radhika Beri
Radhika Beri currently holds 1 directorship: Recombigen Laboratories Private Limited (Director, since 20 Apr 2022, revenue ₹17.85 Cr (FY 2025)).
Radhika Beri was first appointed on 03 Apr 1995 as Director at Clonazyme Healthcare Private Limited. The most recent appointment on record is 20 Apr 2022 at Recombigen Laboratories Private Limited.
Radhika Beri held 1 earlier board appointment: Clonazyme Healthcare Private Limited (Director, from 03 Apr 1995).
The current boards of Radhika Beri's companies include Rajesh Beri (Recombigen Laboratories Private Limited).